secwatch.observer — SEC 8-K summary
======================================

Issuer:     Newcourt Acquisition Corp (—)
CIK:        0001849475
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001104659-24-008879
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NCAC completes merger with Psyence Biomedical; Psyence Biomed lists on Nasdaq under PBM
--------------------------------------------------------------------------------

- Business combination closed Jan 25, 2024; Psyence Biomedical now trading on Nasdaq starting Jan 26 under PBM (common) and PBMWW (warrants).
- Up to $10M raised via senior secured convertible notes from US investment firm to fund clinical trials.
- New board and officers: Dr. Neil Maresky (CEO), Jody Aufrichtig (Chairman), Warwick Corden-Lloyd (CFO).
- Minimum cash condition ($20M) and PIPE investment condition waived to enable closing.
- NCAC's securities delisted from Nasdaq; intends to file Form 15 to terminate registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1849475/000110465924008879/0001104659-24-008879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1849475/000110465924008879/tm244743d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-008879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer